TrialHuman vaccines & immunotherapeutics2012

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years.

Timo Vesikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.